Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract
Study Details
Study Description
Brief Summary
Laparoscopic Ultrasound (LUS) is an important part of the pre-treatment evaluation of patients with upper gastrointestinal tract cancer (esophageal, gastric, pancreatic and liver cancer). When a suspect lesion is visualized during LUS a biopsy should be provided in order to differentiate between benign and malignant lesions. A new system for LUS guided biopsy has been developed, but how often these biopsies are clinically relevant (i.e. changing patient management)and how reliable are these biopsies are unknown.
The study hypothesis is that LUS guided biopsies are accurate and clinically relevant in the pre-treatment evaluation of patients with upper gastrointestinal tract cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Biopsy proven upper GI tract cancer
-
Laparoscopic Ultrasound indicated during pre-treatment evaluation
Exclusion Criteria:
- Patients unfit for surgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Surgery, Odense University Hospital | Odense | Denmark | 5000 |
Sponsors and Collaborators
- Odense University Hospital
Investigators
- Principal Investigator: Michael B Mortensen, MD, Ph.D., Department of Surgery, Odense University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2007-10